Key Takeaways

•A new review of six big studies shows magic mushrooms can help treat deep sadness.

•The drug works better than a fake pill, but only when given at a full dose.

•Small doses, or microdoses, did not show the same strong benefits.

•This research offers hope for people whose sadness has not improved with normal treatments.

Can magic mushrooms really help treat deep sadness, and what dose is needed?

Yes, magic mushrooms can help treat deep sadness, but it requires a full dose to work well. A recent review of six big studies found that full doses of the drug beat fake pills in reducing sadness, while small doses did not (1).

For many people in Texas, living with deep sadness feels like an endless battle. When normal pills and talk therapy do not work, it is easy to feel stuck. This is called treatment-resistant depression. Because of this, scientists are looking for new ways to help. One of the most talked-about new options is psilocybin, the active part of magic mushrooms. But does it really work? In this post, we will look at what the latest science says about using this drug for sadness and why the dose matters so much.

What did the new review of studies find?

The new review found that magic mushrooms are much better at treating deep sadness than a fake pill. It looked at six large, well-run studies to see how well the drug works (1).

When researchers combined the data from these six studies, the results were clear. People who took the drug saw a big drop in their sadness and low mood. This drop was much larger than what was seen in people who took a fake pill (1). This is huge news for people who have tried many other treatments without success (2). If you are looking into Depression Therapy, knowing about these new findings can give you hope.

Why is a full dose needed for it to work?

A full dose is needed because it creates the deep brain changes required to break the cycle of sadness. Small doses do not trigger these same strong changes (3).

The review showed that only the full dose, usually around 25 milligrams, had a strong effect. The smaller doses, like 1 or 10 milligrams, did not work much better than a fake pill (1). This means that the deep, sometimes intense, trip is a key part of the healing process. The full dose helps the brain reset and form new, healthier paths (2). This is why Integrative Post-Psychedelic Support is so vital. It helps people make sense of the strong feelings that come up during a full-dose session.

Is this treatment safe for everyone?

While it shows great promise, it is not safe for everyone and must be done in a clinic. Some people may have bad reactions, so careful screening is needed (4).

The studies showed that most people handled the drug well when they were in a safe, controlled space with trained guides. However, some people did feel anxious or had a headache during the trip (4). Because the full dose causes a strong shift in reality, it is not meant to be taken alone or casually. As we learn more, it is clear that The Safety of Psilocybin: What Clinical Trials Reveal. The setting and the support you have are just as important as the drug itself.

Conclusion

In short, a new review of six big studies shows that magic mushrooms can be a strong tool against deep sadness, but only when given at a full dose (1). Small doses do not offer the same deep healing (3). This research brings new hope to those who have not found relief with normal treatments (2).

If you are dealing with deep sadness, you do not have to face it alone. Healing is possible, and knowing your options is the first step.

Ready to explore your path to healing? Contact me today to schedule an appointment.

About the Author

This article was written by Jeff Jones, a Licensed Professional Counselor (LPC) in Texas in practice since 1999. He is a 2024 graduate of the CIIS Center for Psychedelic Therapies and Research program. With a compassionate and evidence-based approach, he helps clients navigate life's challenges and find a path toward healing.

Disclaimer

The information in this article, including discussions of psychedelic-assisted psychotherapy, is for informational purposes only. Psychedelic-assisted psychotherapy has not been approved by all regulatory agencies in the United States, and its safety and efficacy are still being established. This content is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

(1) Kishi, T., et al. (2026). Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis. Journal of Affective Disorders. https://www.sciencedirect.com/science/article/abs/pii/S0165032726005264

(2) Goodwin, G. M., et al. (2022). Single-dose psilocybin for a treatment-resistant episode of major depression. New England Journal of Medicine, 387, 1637–1648. https://www.nejm.org/doi/full/10.1056/NEJMoa2206443

(3) Swieczkowski, D., et al. (2025). Efficacy and safety of psilocybin in the treatment of major depressive disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials. Psychiatry Research. https://www.sciencedirect.com/science/article/pii/S016517812400622X

(4) Mertens, L. J., et al. (2026). Efficacy and safety of psilocybin in treatment-resistant major depression: the EPISODE randomized clinical trial. JAMA Psychiatry. https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2846478